Episode 21-32 SMA, NMOSD and Aging – From Few to Everyone

On this week’s Tech Nation, Moira speaks with Dr. Levi Garraway, the Chief Medical Officer of Genentech about FDA approvals for treatments in two very rare diseases - SMA - Spinal Muscular Atrophy, and NMOSD - Neuromyelitis Optica Spectrum Disorder. Then Dr. Thomas Rando, Co-Founder of Fountain Therapeutics, a Professor at Stanford University School of Medicine, and Director of Glen Laboratories on the Biology of Aging talks about a rampant medical condition – aging.